Synthetic integrin-binding immune stimulators target cancer cells and prevent tumor formation
出版年份 2017 全文链接
标题
Synthetic integrin-binding immune stimulators target cancer cells and prevent tumor formation
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-12-08
DOI
10.1038/s41598-017-17627-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cyclophosphamide Enhances Human Tumor Growth in Nude Rat Xenografted Tumor Models
- (2015) Yingjen Jeffrey Wu et al. NEOPLASIA
- Identification of Formyl Peptides from Listeria monocytogenes and Staphylococcus aureus as Potent Chemoattractants for Mouse Neutrophils
- (2014) E. L. Southgate et al. JOURNAL OF IMMUNOLOGY
- Chemically Synthesized Molecules with the Targeting and Effector Functions of Antibodies
- (2014) Patrick J. McEnaney et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Replacing Antibodies: Engineering New Binding Proteins
- (2013) Scott Banta et al. Annual Review of Biomedical Engineering
- Structural Determinants for the Interaction of Formyl Peptide Receptor 2 with Peptide Ligands
- (2013) Hui-Qiong He et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting tumors with nanobodies for cancer imaging and therapy
- (2013) Sabrina Oliveira et al. JOURNAL OF CONTROLLED RELEASE
- Antibody-Recruiting Molecules: An Emerging Paradigm for Engaging Immune Function in Treating Human Disease
- (2012) Patrick J. McEnaney et al. ACS Chemical Biology
- Antibody-Based Immunotherapy of Cancer
- (2012) Louis M. Weiner et al. CELL
- Immunomodulatory therapy of cancer with T cell-engaging BiTE antibody blinatumomab
- (2011) Dirk Nagorsen et al. EXPERIMENTAL CELL RESEARCH
- Breast cancer stem cells, cytokine networks, and the tumor microenvironment
- (2011) Hasan Korkaya et al. JOURNAL OF CLINICAL INVESTIGATION
- Engineering Antibodies for Cancer Therapy
- (2011) Eric T. Boder et al. Annual Review of Chemical and Biomolecular Engineering
- Next generation of antibody therapy for cancer
- (2011) Zhenping Zhu et al. Chinese Journal of Cancer
- Affibody molecules: Engineered proteins for therapeutic, diagnostic and biotechnological applications
- (2010) J. Löfblom et al. FEBS LETTERS
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
- (2010) Markus M. Heiss et al. INTERNATIONAL JOURNAL OF CANCER
- Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules
- (2010) R. P. Baum et al. JOURNAL OF NUCLEAR MEDICINE
- Chemical generation of bispecific antibodies
- (2010) V. R. Doppalapudi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Therapeutic antibodies: successes, limitations and hopes for the future
- (2009) Patrick Chames et al. BRITISH JOURNAL OF PHARMACOLOGY
- Bispecific T-Cell Engaging Antibodies for Cancer Therapy
- (2009) P. A. Baeuerle et al. CANCER RESEARCH
- Synergistic Induction of Inflammation by Bacterial Products Lipopolysaccharide and fMLP: An Important Microbial Pathogenic Mechanism
- (2009) L.-Y. Chen et al. JOURNAL OF IMMUNOLOGY
- Structure −Activity Relationship Studies of Targeting Ligands against Breast Cancer Cells
- (2009) Nianhuan Yao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Multivalency: the hallmark of antibodies used for optimization of tumor targeting by design
- (2008) Sergey M. Deyev et al. BIOESSAYS
- Alternative binding proteins: Anticalins - harnessing the structural plasticity of the lipocalin ligand pocket to engineer novel binding activities
- (2008) Arne Skerra FEBS Journal
- Discovery of Targeting Ligands for Breast Cancer Cells Using the One-Bead One-Compound Combinatorial Method
- (2008) Nianhuan Yao et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation